Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/54151
Type: Artigo de periódico
Title: ACTIVATION BY PHONEUTRIA-NIGRIVENTER (ARMED SPIDER) VENOM OF TISSUE KALLIKREIN-KININOGEN-KININ SYSTEM IN RABBIT SKIN INVIVO
Author: MARANGONI, RA
ANTUNES, E
BRAIN, SD
DENUCCI, G
Abstract: 1 The purpose of the present study was to investigate the mechanisms by which venom from Phoneutria nigriventer spider induces increases in vascular permeability in rabbit skin. 2 Local oedema formation, in response to intradermally-injected agents, was measured in male New Zealand white rabbits as the local accumulation of i.v. injected I-125-labelled human serum albumin into skin sites. 3 Phoneutria nigriventer venom (10-30 mug/site) increased vascular permeability, which was inhibited by trasylol (10 mug/site) and the bradykinin B2 receptor antagoniStS D-Arg,[Hyp3,Thi5,8,D-Phe7]-BK (3 nmol/site) and Hoe 140 (0.3 nmol/site). In addition, the oedema induced by the venom was potentiated by the kinase II inhibitor, captopril (1 nmol/site). The lipoxygenase inhibitor, BWA4C (10 nmol/site) and the PAF antagonist, WEB 2086 (100 nmol/site) had no effect on the venom-induced increase in vascular permeability. 4 Incubation of rabbit plasma with Phoneutria nigriventer venom in vitro did not cause bradykinin formation. Further, the plasma kallikrein inhibitor, soybean trypsin inhibitor (10 mug/site), had no effect on the venom-induced increase in vascular permeability in rabbit skin. 5 These results indicate that the oedema produced by Phoneutria nigriventer venom is dependent on the activation of the tissue kallikrein-kinin system.
Subject: TRASYLOL
BRADYKININ
KALLIDIN
SOYBEAN TRYPSIN INHIBITOR
CAPTOPRIL
EDEMA
PHONEUTRIA-NIGRIVENTER
Country: Inglaterra
Editor: Stockton Press
Rights: fechado
Date Issue: 1993
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOSA1993LE28700039.pdf1.09 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.